Table 1.
Groups | n | Gray value (
± SE)
|
|
---|---|---|---|
MMP-2 | MMP-9 | ||
A | 6 | 168.3±5.7## | 167.8±5.3## |
B1 | 6 | 174.0±5.0## | 174.2±1.8## |
B2 | 6 | 178.8±7.0## | 178.5±3.2## |
C1 | 6 | 183.0±2.9*,# | 177.8±7.5# |
C2 | 6 | 184.5±4.8*,# | 189.0±7.2* |
D1 | 6 | 187.0±5.0* | 192.5±5.4**,▲ |
D2 | 6 | 199.5±3.6** | 202.2±3.9** |
Notes: For MMP-2 and MMP-9 respectively
P<0.05
P<0.01 versus the A group
P<0.05
P<0.01 versus the D2 group
P<0.05 versus the B1 group. A, control group; B1, paclitaxel 15 mg/kg; B2, paclitaxel 30 mg/kg; C1, paclitaxel-containing mixed micelles at 15 mg/kg; C2, paclitaxel-containing mixed micelles at 30 mg/kg; D1, folic acid and paclitaxel-containing mixed micelles at 15 mg/kg; D2, folic acid and paclitaxel-containing mixed micelles at 30 mg/kg.
Abbreviations: IHC, immunohistochemistry; H22, hepatoma 22; n, number; SE, standard error; MMP, matrix metalloproteinase.